We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+3.64%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$74.9B
AUM Growth
+$9.23B
Cap. Flow
+$7.27B
Cap. Flow %
9.7%
Top 10 Hldgs %
32.66%
Holding
3,137
New
748
Increased
792
Reduced
857
Closed
654

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$3.04B
2
MSFT icon
Microsoft
MSFT
+$830M
3
AMZN icon
Amazon
AMZN
+$550M
4
JNJ icon
Johnson & Johnson
JNJ
+$483M
5
AAPL icon
Apple
AAPL
+$470M

Sector Composition

Rank Sector Weight
1 Technology 18.7%
2 Consumer Discretionary 13.75%
3 Healthcare 12.4%
4 Financials 7.81%
5 Industrials 6.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARE icon
401
Alexandria Real Estate Equities
ARE
$8.88B
$26.7M 0.04%
228,232
-38,704
-14% -$4.61M
VVV icon
402
Valvoline
VVV
$4.97B
$26.7M 0.04%
617,694
+80,450
+15% +$3.38M
LIVN icon
403
LivaNova
LIVN
$4.3B
$26.7M 0.04%
486,638
-225,194
-32% -$12.8M
CM icon
404
Canadian Imperial Bank of Commerce
CM
$107B
$26.5M 0.04%
556,864
-42,970
-7% -$2.08M
CTSH icon
405
Cognizant
CTSH
$21.5B
$26.5M 0.04%
+388,978
New +$26.4M
NVT icon
406
nVent Electric
NVT
$24.5B
$26M 0.03%
339,371
+169,683
+100% +$13.2M
KO icon
407
CALL
Coca-Cola
KO
$354B
$26M 0.03%
+407,800
New +$25.2M
AIG icon
408
American International
AIG
$41.9B
$25.9M 0.03%
349,341
+335,871
+2,493% +$25.7M
DGX icon
409
Quest Diagnostics
DGX
$25.1B
$25.9M 0.03%
189,025
-397,174
-68% -$54.4M
BERY
410
DELISTED
Berry Global Group, Inc.
BERY
$25.7M 0.03%
+475,340
New +$25.8M
CBRL icon
411
Cracker Barrel
CBRL
$1.2B
$25.6M 0.03%
+608,062
New +$32.6M
EXR icon
412
Extra Space Storage
EXR
$31.2B
$25.6M 0.03%
+164,736
New +$24M
JNPR
413
PUT
DELISTED
Juniper Networks
JNPR
$25.5M 0.03%
+699,000
New +$24.8M
MCD icon
414
McDonald's
MCD
$188B
$25.5M 0.03%
100,000
-100,392
-50% -$26.6M
PLAY icon
415
Dave & Buster's
PLAY
$343M
$25.5M 0.03%
640,096
+170,286
+36% +$8.85M
AER icon
416
AerCap
AER
$23.9B
$25.3M 0.03%
+271,066
New +$24.1M
TTC icon
417
Toro Company
TTC
$8.93B
$25.2M 0.03%
+269,125
New +$23.7M
XBI icon
418
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$25.1M 0.03%
+271,000
New +$24.3M
IBM icon
419
PUT
IBM
IBM
$202B
$25.1M 0.03%
+145,000
New +$25.2M
RPRX icon
420
Royalty Pharma
RPRX
$26.1B
$24.9M 0.03%
945,840
-510,060
-35% -$14.1M
DOV icon
421
Dover
DOV
$27.2B
$24.9M 0.03%
137,807
-76,428
-36% -$13.7M
NVDA icon
422
PUT
NVIDIA
NVDA
$5.01T
$24.8M 0.03%
201,000
-657,000
-77% -$66.4M
NOV icon
423
NOV
NOV
$7.45B
$24.8M 0.03%
1,303,995
-1,756,947
-57% -$32.9M
KRE icon
424
CALL
State Street SPDR S&P Regional Banking ETF
KRE
$4.86B
$24.7M 0.03%
503,900
-620,200
-55% -$29.9M
AMED
425
DELISTED
Amedisys
AMED
$24.6M 0.03%
268,122
-23,381
-8% -$2.17M

Similar funds

Marshall Wace's Q2 2024 Portfolio in Review

As of Q2 2024, Marshall Wace held 3,137 positions worth $74.9B, up 14% from $65.7B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Marshall Wace deployed $7.27B of net new capital in Q2 2024, opening 748 new positions and adding to 792 existing holdings. Its largest new stake was GE Vernova: 2,330,887 shares worth $400M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Procter & Gamble, an estimated $474M trimmed.

  • Marshall Wace's largest Q2 2024 buy was GE Vernova: 2,330,887 shares worth $400M.
  • Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $3.04B increase.
  • Marshall Wace's biggest Q2 2024 reduction was Procter & Gamble, cutting an estimated $474M.
  • Marshall Wace fully exited Applied Materials in Q2 2024, selling an estimated $127M.
  • Marshall Wace's ten largest holdings make up 33% of its $74.9B portfolio in Q2 2024.
  • Marshall Wace opened 748 new positions and closed 654 in Q2 2024.
  • Marshall Wace's portfolio value rose 14% quarter-over-quarter to $74.9B.

Based on Marshall Wace's 13F filing for Q2 2024, filed 14 Aug 2024.